Top Markets
#1 Islamic Coin Islamic Coin +151.46%
#2 DOVU DOVU +50.34%
#3 Velvet Velvet +40.04%
#4 Black Phoenix Black Phoenix +35.02%
#5 Fake World Assets Fake World Assets +19.47%
#6 FGRS (Figure Tokenized Stock) FGRS (Figure Tokenized Stock) +19.10%
#7 Palladium Network Palladium Network +19.08%
#8 Akedo Akedo +17.40%
#9 DoubleZero DoubleZero +16.63%
#10 HOME HOME +13.53%
Coin of the day
Islamic Coin Islamic Coin
Impostazioni
Lingua
ITALIANO
Valuta
USD
Tema
Reviva Pharmaceuticals Holdings, Inc. Reviva Pharmaceuticals Holdings, Inc.

Reviva Pharmaceuticals Holdings, Inc.

RVPHW
Classifica tra le azioni #39800
Reviva Pharmaceuticals Holdings, Inc. is a clinical-stage biopharmaceutical... Reviva Pharmaceuticals Holdings, Inc. is a clinical-stage biopharmaceutical company focused on discovering, developing, and commercializing innovative therapies for diseases with substantial unmet medical needs. Their pipeline targets disorders within the central nervous system, respiratory, cardiovascular, metabolic, and inflammatory disease categories. The company's leading drug candidate, brilaroxazine (RP5063), is currently in Phase III clinical trials for the treatment of schizophrenia. This compound has also completed Phase I trials for a diverse set of conditions, including bipolar disorder, major depressive disorder, attention-deficit/hyperactivity disorder, the behavioral and psychotic symptoms of dementia or Alzheimer's disease, Parkinson's disease psychosis, pulmonary arterial hypertension, and idiopathic pulmonary fibrosis. Furthermore, Reviva is advancing RP1208, which is in pre-clinical development for depression and obesity. Founded in 2018, the company is headquartered in Cupertino, California.
Prezzo delle azioni
$0.003
Ultima sincronizzazione: 2025-12-12
Capitalizzazione di mercato
$343.91K
Variazione (1 giorno)
-16.67%
Variazione (1 anno)
-90.23%
Paese
US
Scambia Reviva Pharmaceuticals Holdings, Inc. (RVPHW)

Categoria

Healthcare
Storico del prezzo dell'azione per Reviva Pharmaceuticals Holdings, Inc. (RVPHW)
Prezzo di chiusura più alto: $0.01 il 2025-12-01

Prezzo di chiusura più basso: $0.33 il 2018-10-01
Storico del prezzo dell'azione di Reviva Pharmaceuticals Holdings, Inc. dal 2018 al 2026
Andamento annuale del prezzo dell'azione
Anno Performance
2026 (TTM) 305.88%
2025 -96.70%
2024 -75.67%
2023 0.82%
2022 134.68%
2021 -39.09%
2020 167.36%
2019 -15.00%
2018 0.00%
Prezzo dell'azione per aziende simili o concorrenti
Azienda Prezzo dell'azione Variazione 1a% Il paese
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
 $517.18 32.51%
US
Argenx SE Argenx SE
Argenx SE
ARGX.US
 $857.76 31.47%
NL
Lonza Group AG Lonza Group AG
Lonza Group AG
LONN.SW
 $745.22 9.11%
CH
Samsung Biologics Co.,Ltd. Samsung Biologics Co.,Ltd.
Samsung Biologics Co.,Ltd.
207940.KS
 $1.07K -6.40%
KR
UCB S.A. UCB S.A.
UCB S.A.
UCB.BR
 $258.46 14.18%
BE